» Articles » PMID: 29439081

Long-term Trends of Liver Cancer Mortality by Gender in Urban and Rural Areas in China: an Age-period-cohort Analysis

Overview
Journal BMJ Open
Specialty General Medicine
Date 2018 Feb 14
PMID 29439081
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To provide an up-to-date overview of long-term trends of liver cancer mortality and evaluate the effects attributable to age, period and cohort in Chinese population stratified by gender and urban/rural areas.

Methods: Population and liver cancer mortality data were obtained based on the Disease Surveillance Points in China from 1991 to 2014. To examine the time trends of liver cancer mortality by gender in urban and rural areas in China, Joinpoint analysis was used to estimate the annual per cent change. The intrinsic estimator, a method of age-period-cohort analysis to estimate age, period and cohort effects simultaneously, was used to analyse the underlying mechanisms for liver cancer mortality trends in the aforementioned four groups.

Results: We observed a significant decline in liver cancer mortality for urban men (average annual per cent change (AAPC)=-1.1%, P<0.05) and urban women (AAPC=-1.4%, P<0.05), while the liver cancer mortality remained stable for rural men (AAPC=-0.1%, P>0.05) and rural women (AAPC=-0.9%, P>0.05). Compared with the 15-19 age group, the liver cancer mortality risk of the 85 and above age group increased 65 and 42 times for urban and rural men, and 102 and 70 times for urban and rural women. From the 1990-1994 period to the 2005-2009 period, the risk increased 56% and 92% for urban and rural men, and 30% and 74% for urban and rural women. Compared with period and cohort effects, age effects were the most influential factor in liver cancer mortality.

Conclusions: As the status of ageing population in China gets worse, the burden caused by liver cancer mortality could still be a great challenge for China in the future. The disparity of liver cancer mortality trends between urban and rural residents can be attributed to period effects, referring to the unequal medical levels and resources between urban and rural areas.

Citing Articles

Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma.

Zhang S, Tuo P, Ji Y, Huang Z, Xiong Z, Li H J Cancer Res Clin Oncol. 2024; 150(6):310.

PMID: 38890166 PMC: 11189347. DOI: 10.1007/s00432-024-05848-6.


Trend analysis and age-period-cohort effects on morbidity and mortality of liver cancer from 2010 to 2020 in Guangzhou, China.

Wang D, Hu X, Xu H, Chen Y, Wang S, Lin G Front Oncol. 2024; 14:1387587.

PMID: 38756657 PMC: 11096536. DOI: 10.3389/fonc.2024.1387587.


Mortality Burden of Liver Cancer in China: An Observational Study From 2008 to 2020.

Liu H, Wang X, Wang L, Yin P, Liu F, Wei L J Clin Transl Hepatol. 2024; 12(4):371-380.

PMID: 38638380 PMC: 11022066. DOI: 10.14218/JCTH.2023.00455.


Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage.

Wei S, Xie Q, Liao G, Chen H, Hu M, Lin X BMC Gastroenterol. 2024; 24(1):120.

PMID: 38532310 PMC: 10967107. DOI: 10.1186/s12876-024-03208-9.


Trends of Mortality in End-Stage Liver Disease - China, 2008-2020.

Wang X, Liu H, Qi J, Zeng F, Wang L, Yin P China CDC Wkly. 2023; 5(30):657-663.

PMID: 37593126 PMC: 10427498. DOI: 10.46234/ccdcw2023.128.


References
1.
Zheng R, Zuo T, Zeng H, Zhang S, Chen W . [Mortality and survival analysis of liver cancer in China]. Zhonghua Zhong Liu Za Zhi. 2016; 37(9):697-702. View

2.
Beal E, Tumin D, Kabir A, Moris D, Zhang X, Chakedis J . Trends in the Mortality of Hepatocellular Carcinoma in the United States. J Gastrointest Surg. 2017; 21(12):2033-2038. DOI: 10.1007/s11605-017-3526-7. View

3.
Guo K, Yin P, Wang L, Ji Y, Li Q, Bishai D . Propensity score weighting for addressing under-reporting in mortality surveillance: a proof-of-concept study using the nationally representative mortality data in China. Popul Health Metr. 2015; 13:16. PMC: 4496861. DOI: 10.1186/s12963-015-0051-3. View

4.
Park J, Jee Y . Age-Period-Cohort Analysis of Liver Cancer Mortality in Korea. Asian Pac J Cancer Prev. 2016; 16(18):8589-94. DOI: 10.7314/apjcp.2015.16.18.8589. View

5.
Lee L, Huang H, Huang K, Chen C, Lee W . Age-period-cohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976-2005. Ann Epidemiol. 2009; 19(5):323-8. DOI: 10.1016/j.annepidem.2008.12.013. View